Reason for request
Re-assessment of the Actual Benefit and Improvement in Actual Benefit for the symptomatic treatment of idiopathic restless legs syndrome (RLS at the request of the Committee (pursuant to article R 163-21 of the French Social Security Code).
Clinical Benefit
| Moderate |
Moderate in patients with very severe idiopathic RLS. |
Clinical Added Value
| minor |
SIFROL provides a minor improvement in actual benefit (IAB IV) in the management of patients with very severe idiopathic restless legs syndrome. |
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
uBCHasEM9QPJHxkg
